Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 3 | 0 | 0 | 3 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 3 | 0 | 0 | 3 |
phosphopantetheinyl transferase | 11 | 0 | 0 | 11 |
bromodomain adjacent to zinc finger domain 2B | 6 | 0 | 0 | 6 |
euchromatic histone-lysine N-methyltransferase 2 | 24 | 0 | 0 | 24 |
pyruvate kinase PKM isoform a | 1 | 0 | 0 | 1 |
geminin | 33 | 0 | 0 | 33 |
Glycoprotein hormones alpha chain | 1 | 0 | 0 | 1 |
Guanine nucleotide-binding protein G | 5 | 0 | 0 | 5 |
Tubulin--tyrosine ligase | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2C | 0 | 2 | 1 | 3 |
5-hydroxytryptamine receptor 2A | 0 | 2 | 1 | 3 |
5-hydroxytryptamine receptor 1A | 0 | 8 | 3 | 11 |
5-hydroxytryptamine receptor 1B | 0 | 5 | 1 | 6 |
5-hydroxytryptamine receptor 1D | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 1F | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 2B | 0 | 2 | 1 | 3 |
5-hydroxytryptamine receptor 6 | 0 | 0 | 1 | 1 |
Sodium-dependent serotonin transporter | 0 | 6 | 1 | 7 |
Sodium-dependent serotonin transporter | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 7 | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 5A | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 5B | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 3A | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 3B | 0 | 0 | 1 | 1 |
aldehyde dehydrogenase 1 family, member A1 | 13 | 0 | 0 | 13 |
regulator of G-protein signaling 4 | 10 | 0 | 0 | 10 |
Trypsin | 0 | 1 | 0 | 1 |
Coagulation factor VII | 0 | 1 | 0 | 1 |
Tissue factor | 0 | 1 | 0 | 1 |
Oxoeicosanoid receptor 1 | 0 | 1 | 0 | 1 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 11 | 0 | 0 | 11 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, Carbonic Anhydrase Ii | 0 | 0 | 1 | 1 |
Chain A, Carbonic Anhydrase Ii | 0 | 0 | 1 | 1 |
Chain A, Beta-lactamase | 17 | 0 | 0 | 17 |
Chain A, Endochitinase | 0 | 1 | 0 | 1 |
Chain A, Endochitinase | 0 | 1 | 0 | 1 |
Chain A, Endochitinase | 0 | 1 | 0 | 1 |
Chain A, Class Iii Chitinase Chia1 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase II | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase | 0 | 1 | 0 | 1 |
Chain B, Carbonic anhydrase | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
thioredoxin reductase | 15 | 0 | 0 | 15 |
GALC protein | 6 | 0 | 0 | 6 |
GLI family zinc finger 3 | 23 | 0 | 0 | 23 |
nuclear receptor subfamily 1, group I, member 3 | 18 | 0 | 0 | 18 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 21 | 0 | 0 | 21 |
glucocorticoid receptor [Homo sapiens] | 25 | 0 | 0 | 25 |
retinoic acid nuclear receptor alpha variant 1 | 25 | 0 | 0 | 25 |
retinoid X nuclear receptor alpha | 18 | 0 | 0 | 18 |
estrogen-related nuclear receptor alpha | 24 | 0 | 0 | 24 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
arylsulfatase A | 9 | 0 | 0 | 9 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Bloom syndrome protein isoform 1 | 7 | 0 | 0 | 7 |
thyroid hormone receptor beta isoform a | 10 | 0 | 0 | 10 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 20 | 0 | 0 | 20 |
peripheral myelin protein 22 | 10 | 0 | 0 | 10 |
survival motor neuron protein isoform d | 6 | 0 | 0 | 6 |
muscleblind-like protein 1 isoform 1 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit pi | 8 | 1 | 2 | 11 |
ATP-binding cassette sub-family C member 3 | 0 | 27 | 0 | 27 |
Multidrug resistance-associated protein 4 | 0 | 27 | 0 | 29 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 4 | 0 | 5 |
Carbonic anhydrase 12 | 0 | 8 | 2 | 18 |
Prolyl endopeptidase | 0 | 1 | 0 | 1 |
Carbonic anhydrase-related protein 11 | 0 | 1 | 0 | 2 |
Bile salt export pump | 0 | 35 | 0 | 35 |
Glycogen phosphorylase, muscle form | 0 | 2 | 0 | 2 |
Renin | 0 | 3 | 0 | 3 |
Carbonic anhydrase 1 | 0 | 13 | 2 | 25 |
Carbonic anhydrase 2 | 0 | 14 | 2 | 26 |
Carbonic anhydrase 2 | 0 | 2 | 0 | 2 |
Cytochrome P450 1A2 | 0 | 3 | 0 | 4 |
Carbonic anhydrase 3 | 0 | 7 | 2 | 14 |
Cathepsin B | 0 | 1 | 0 | 1 |
Cytochrome P450 3A4 | 0 | 9 | 0 | 11 |
Steryl-sulfatase | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
Cytochrome P450 2C8 | 0 | 2 | 0 | 2 |
Cytochrome P450 2D6 | 0 | 6 | 0 | 6 |
Cytochrome P450 2A6 | 0 | 1 | 0 | 1 |
Cytochrome P450 2C9 | 0 | 12 | 0 | 13 |
Androgen receptor | 0 | 4 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit beta-1 | 8 | 1 | 2 | 11 |
Translocator protein | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit delta | 8 | 1 | 2 | 11 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 8 | 1 | 2 | 11 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 8 | 1 | 2 | 11 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 8 | 1 | 2 | 11 |
Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
Arachidonate 5-lipoxygenase-activating protein | 0 | 1 | 0 | 1 |
Cytochrome P450 2B6 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 13 | 2 | 22 |
Carbonic anhydrase 6 | 0 | 7 | 2 | 16 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 8 | 1 | 2 | 11 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 8 | 1 | 2 | 11 |
Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 4 | 0 | 6 |
Serum paraoxonase/arylesterase 1 | 0 | 2 | 0 | 2 |
Dipeptidyl peptidase 4 | 0 | 2 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 8 | 1 | 2 | 11 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 8 | 1 | 2 | 11 |
Endochitinase | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 8 | 1 | 2 | 11 |
Adenosine receptor A2a | 0 | 5 | 0 | 7 |
Delta-type opioid receptor | 0 | 4 | 1 | 6 |
Cytochrome P450 2C19 | 0 | 4 | 0 | 4 |
Delta-type opioid receptor | 0 | 2 | 0 | 2 |
Mu-type opioid receptor | 0 | 4 | 0 | 4 |
Carbonic anhydrase 5A, mitochondrial | 0 | 8 | 2 | 18 |
Carbonic anhydrase | 0 | 5 | 0 | 8 |
Kappa-type opioid receptor | 0 | 3 | 1 | 4 |
Carbonic anhydrase 7 | 0 | 8 | 2 | 17 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
D(1A) dopamine receptor | 2 | 1 | 0 | 3 |
Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 2 | 0 | 2 |
Carbonic anhydrase | 0 | 1 | 0 | 5 |
D(2) dopamine receptor | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 8 | 1 | 2 | 11 |
Gamma-aminobutyric acid receptor subunit beta-3 | 8 | 1 | 2 | 11 |
Gamma-aminobutyric acid receptor subunit beta-2 | 8 | 1 | 2 | 11 |
Cholinesterase | 0 | 2 | 0 | 2 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 4 | 0 | 4 |
Fatty-acid amide hydrolase 1 | 0 | 3 | 0 | 3 |
Beta-carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 1 | 1 | 5 |
Squalene synthase | 0 | 3 | 0 | 3 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 9 | 0 | 8 | 2 | 18 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
Carbonic anhydrase, alpha family | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 5 |
Carbonic anhydrase 3 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 6 |
Carbonic anhydrase | 0 | 1 | 0 | 6 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
Delta carbonic anhydrase | 0 | 1 | 0 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
Renin | 0 | 2 | 0 | 2 |
Carbonic anhydrase | 0 | 1 | 0 | 5 |
Endochitinase A1 | 0 | 1 | 0 | 1 |
Multidrug resistance-associated protein 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 3 | 2 | 7 |
GABA theta subunit | 8 | 1 | 2 | 11 |
Canalicular multispecific organic anion transporter 1 | 0 | 25 | 0 | 26 |
Carbonic anhydrase 4 | 0 | 2 | 0 | 3 |
Carbonic anhydrase 15 | 0 | 6 | 0 | 10 |
Acidic mammalian chitinase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 6 | 0 | 12 |
Carbonic anhydrase 7 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit epsilon | 8 | 1 | 2 | 11 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 14 | 0 | 7 | 2 | 17 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 2, isoform A | 0 | 1 | 0 | 1 |
Carbonic anhydrase 5B, mitochondrial | 0 | 7 | 2 | 17 |
TDP1 protein | 25 | 0 | 0 | 25 |
chromobox protein homolog 1 | 15 | 0 | 0 | 15 |
Chain A, 2-oxoglutarate Oxygenase | 9 | 0 | 0 | 9 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 3 | 0 | 0 | 3 |
acetylcholinesterase | 8 | 0 | 0 | 8 |
dopamine D1 receptor | 2 | 0 | 0 | 2 |
15-lipoxygenase, partial | 3 | 0 | 0 | 3 |
pregnane X receptor | 3 | 0 | 0 | 3 |
RAR-related orphan receptor gamma | 22 | 0 | 0 | 22 |
USP1 protein, partial | 12 | 0 | 0 | 12 |
NFKB1 protein, partial | 6 | 0 | 0 | 6 |
Microtubule-associated protein tau | 11 | 0 | 0 | 11 |
Thrombopoietin | 1 | 0 | 0 | 1 |
AR protein | 31 | 0 | 0 | 31 |
farnesoid X nuclear receptor | 11 | 0 | 0 | 11 |
estrogen nuclear receptor alpha | 34 | 0 | 0 | 34 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 22 | 0 | 0 | 22 |
D(1A) dopamine receptor | 4 | 0 | 0 | 4 |
thyroid hormone receptor beta isoform 2 | 21 | 0 | 0 | 21 |
heat shock protein beta-1 | 4 | 0 | 0 | 4 |
flap endonuclease 1 | 4 | 0 | 0 | 4 |
muscarinic acetylcholine receptor M1 | 6 | 0 | 0 | 6 |
Histone deacetylase 3 | 0 | 3 | 0 | 3 |
Histone deacetylase 4 | 0 | 2 | 0 | 2 |
Histone deacetylase 1 | 0 | 4 | 0 | 4 |
Histone deacetylase 7 | 0 | 2 | 0 | 2 |
Histone deacetylase 2 | 0 | 4 | 0 | 4 |
Polyamine deacetylase HDAC10 | 0 | 1 | 0 | 1 |
Histone deacetylase 11 | 0 | 2 | 0 | 2 |
Ataxin-2 | 11 | 0 | 0 | 11 |
Histone deacetylase 8 | 0 | 2 | 0 | 2 |
Histone deacetylase 6 | 0 | 3 | 0 | 3 |
Histone deacetylase 9 | 0 | 1 | 0 | 1 |
Histone deacetylase 5 | 0 | 2 | 0 | 2 |
ATP-dependent phosphofructokinase | 12 | 0 | 0 | 12 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 13 | 0 | 0 | 13 |
Chain A, MTA/SAH nucleosidase | 0 | 1 | 0 | 1 |
Chain A, Ribosome-inactivating protein alpha-trichosanthin | 0 | 0 | 1 | 1 |
Chain A, Ricin A chain | 0 | 0 | 1 | 1 |
Chain A, Ribosome-inactivating protein 3 | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
pregnane X nuclear receptor | 20 | 0 | 0 | 20 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 16 | 0 | 0 | 16 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 9 | 0 | 0 | 9 |
importin subunit beta-1 isoform 1 | 3 | 0 | 0 | 3 |
snurportin-1 | 3 | 0 | 0 | 3 |
tumor susceptibility gene 101 protein | 1 | 0 | 0 | 1 |
GTP-binding nuclear protein Ran isoform 1 | 2 | 0 | 0 | 2 |
lamin isoform A-delta10 | 19 | 0 | 0 | 19 |
Voltage-dependent calcium channel gamma-2 subunit | 8 | 0 | 0 | 8 |
Cyclin-dependent kinase 1 | 0 | 1 | 0 | 1 |
Heat shock protein HSP 90-beta | 0 | 1 | 0 | 1 |
Glutamate receptor 2 | 9 | 0 | 0 | 9 |
Xanthine dehydrogenase/oxidase | 0 | 4 | 0 | 5 |
TAR DNA-binding protein 43 | 7 | 0 | 0 | 7 |
Protein mono-ADP-ribosyltransferase PARP15 | 0 | 1 | 0 | 1 |
Leucine-rich repeat serine/threonine-protein kinase 2 | 0 | 2 | 0 | 2 |
ATPase family AAA domain-containing protein 5 | 7 | 0 | 0 | 7 |
Sex hormone-binding globulin | 0 | 0 | 2 | 2 |
Corticosteroid-binding globulin | 0 | 1 | 0 | 1 |
Mineralocorticoid receptor | 0 | 6 | 3 | 10 |
Mineralocorticoid receptor | 0 | 3 | 0 | 3 |
Solute carrier organic anion transporter family member 1A1 | 0 | 1 | 0 | 3 |
Fumarate hydratase | 8 | 0 | 0 | 8 |
polyprotein | 8 | 0 | 0 | 8 |
Pepsin A | 0 | 1 | 0 | 1 |
Renin-1 | 0 | 1 | 0 | 1 |
Renin | 0 | 1 | 0 | 1 |
Cathepsin D | 0 | 1 | 0 | 1 |
Renin | 0 | 1 | 0 | 1 |
Protease | 0 | 1 | 0 | 1 |
peroxisome proliferator activated receptor gamma | 18 | 0 | 0 | 18 |
Cellular tumor antigen p53 | 19 | 0 | 0 | 19 |
Thromboxane-A synthase | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP3 subtype | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 1 | 2 |
Prostaglandin E2 receptor EP1 subtype | 0 | 1 | 0 | 1 |
Prostacyclin receptor | 0 | 1 | 1 | 2 |
Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 2 |
Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 1 | 2 |
Solute carrier organic anion transporter family member 2A1 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 2B1 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 3A1 | 0 | 0 | 0 | 1 |
glucocerebrosidase | 3 | 0 | 0 | 3 |
DNA polymerase kappa isoform 1 | 8 | 0 | 0 | 8 |
histone acetyltransferase KAT2A isoform 1 | 7 | 0 | 0 | 7 |
Atrial natriuretic peptide receptor 3 | 0 | 2 | 0 | 2 |
Type-1A angiotensin II receptor | 0 | 6 | 3 | 9 |
Type-1 angiotensin II receptor | 0 | 0 | 1 | 1 |
Type-1B angiotensin II receptor | 0 | 7 | 0 | 7 |
Type-1 angiotensin II receptor | 0 | 7 | 4 | 15 |
Type-2 angiotensin II receptor | 0 | 6 | 0 | 6 |
Type-2 angiotensin II receptor | 0 | 5 | 0 | 5 |
Chain A, Coagulation factor X (EC 3.4.21.6) (Stuart factor) (Stuart-Prower factor) | 0 | 1 | 0 | 1 |
EWS/FLI fusion protein | 21 | 0 | 0 | 21 |
Coagulation factor X | 0 | 1 | 0 | 1 |
Prothrombin | 0 | 4 | 0 | 4 |
Coagulation factor X | 0 | 5 | 0 | 5 |
Trypsin-1 | 0 | 2 | 0 | 2 |
Trypsin-2 | 0 | 2 | 0 | 2 |
Trypsin-3 | 0 | 2 | 0 | 2 |
Spike glycoprotein | 14 | 0 | 0 | 14 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
GLS protein | 8 | 0 | 0 | 8 |
thyroid stimulating hormone receptor | 9 | 0 | 0 | 9 |
alpha-galactosidase | 3 | 0 | 0 | 3 |
cytochrome P450 2C19 precursor | 5 | 0 | 0 | 5 |
DNA polymerase iota isoform a (long) | 10 | 0 | 0 | 10 |
lethal factor (plasmid) | 7 | 0 | 0 | 7 |
Nitric oxide synthase, endothelial | 0 | 0 | 0 | 2 |
Nitric oxide synthase, brain | 0 | 1 | 0 | 2 |
Nitric oxide synthase, brain | 0 | 1 | 0 | 2 |
Nitric oxide synthase, inducible | 0 | 1 | 0 | 2 |
Nitric oxide synthase, inducible | 0 | 0 | 1 | 3 |
Cationic amino acid transporter 3 | 0 | 1 | 0 | 1 |
vitamin D3 receptor isoform VDRA | 10 | 0 | 0 | 10 |
Vasopressin V2 receptor | 0 | 4 | 1 | 6 |
Oxytocin receptor | 0 | 1 | 1 | 2 |
Vasopressin V1a receptor | 0 | 0 | 3 | 3 |
Vasopressin V1a receptor | 0 | 3 | 1 | 4 |
Vasopressin V1b receptor | 0 | 1 | 1 | 2 |
Vasopressin V2 receptor | 0 | 0 | 1 | 1 |
Vasopressin V1b receptor | 0 | 1 | 1 | 3 |
Translocator protein | 0 | 1 | 0 | 2 |
Oxytocin receptor | 0 | 1 | 1 | 2 |
Vasopressin V2 receptor | 0 | 1 | 1 | 2 |
Chain A, Hyaluronidase, phage associated | 0 | 1 | 0 | 1 |
thioredoxin glutathione reductase | 6 | 0 | 0 | 6 |
IDH1 | 8 | 0 | 0 | 8 |
lethal(3)malignant brain tumor-like protein 1 isoform I | 2 | 0 | 0 | 2 |
Polyphenol oxidase 2 | 0 | 1 | 0 | 2 |
Pancreatic alpha-amylase | 0 | 2 | 0 | 2 |
Albumin | 0 | 2 | 0 | 2 |
Urease | 0 | 2 | 0 | 2 |
Prolyl 4-hydroxylase subunit alpha-1 | 0 | 0 | 0 | 1 |
Tyrosinase | 0 | 1 | 0 | 1 |
Alpha-2B adrenergic receptor | 0 | 4 | 1 | 5 |
Hyaluronate lyase | 0 | 1 | 0 | 1 |
Prolyl hydroxylase EGLN2 | 0 | 0 | 0 | 1 |
Egl nine homolog 1 | 0 | 0 | 0 | 1 |
Prolyl hydroxylase EGLN3 | 0 | 0 | 0 | 1 |
Hypoxia-inducible factor 1-alpha inhibitor | 0 | 0 | 0 | 1 |
Solute carrier family 23 member 1 | 0 | 1 | 0 | 1 |
Beta-1 adrenergic receptor | 0 | 0 | 3 | 4 |
Fatty acid-binding protein, liver | 0 | 3 | 1 | 4 |
Beta-2 adrenergic receptor | 0 | 10 | 5 | 16 |
Beta-1 adrenergic receptor | 0 | 10 | 4 | 14 |
Beta-3 adrenergic receptor | 0 | 3 | 4 | 7 |
Alpha-1D adrenergic receptor | 0 | 5 | 1 | 6 |
Alpha-1A adrenergic receptor | 0 | 1 | 1 | 2 |
Alpha-1B adrenergic receptor | 0 | 1 | 1 | 2 |
Beta-2 adrenergic receptor | 0 | 0 | 4 | 4 |
Chain A, Cruzipain | 6 | 0 | 0 | 6 |
SMAD family member 2 | 9 | 0 | 0 | 9 |
SMAD family member 3 | 9 | 0 | 0 | 9 |
caspase 7, apoptosis-related cysteine protease | 3 | 0 | 0 | 3 |
estrogen receptor 2 (ER beta) | 12 | 0 | 0 | 12 |
peroxisome proliferator-activated receptor delta | 14 | 0 | 0 | 14 |
caspase-3 | 3 | 0 | 0 | 3 |
Caspase-7 | 2 | 0 | 0 | 2 |
caspase-3 | 2 | 0 | 0 | 2 |
Solute carrier organic anion transporter family member 2B1 | 0 | 0 | 0 | 1 |
3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 2 | 0 | 2 |
ATP-dependent translocase ABCB1 | 0 | 8 | 1 | 20 |
Insulin receptor | 0 | 1 | 0 | 1 |
Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 3 | 0 | 3 |
3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1B3 | 0 | 9 | 0 | 12 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 6 | 1 | 7 |
Solute carrier organic anion transporter family member 1B1 | 0 | 12 | 0 | 15 |
Atrial natriuretic peptide receptor 1 | 0 | 1 | 1 | 2 |
Atrial natriuretic peptide receptor 1 | 0 | 0 | 1 | 1 |
Glucocorticoid receptor | 0 | 7 | 3 | 10 |
Progesterone receptor | 0 | 5 | 2 | 7 |
Androgen receptor | 0 | 5 | 2 | 7 |
Angiotensin-converting enzyme | 0 | 6 | 0 | 6 |
Angiotensin-converting enzyme | 0 | 4 | 0 | 4 |
Liver carboxylesterase 1 | 0 | 0 | 0 | 1 |
Angiotensin-converting enzyme | 0 | 2 | 0 | 2 |
Chain A, HADH2 protein | 9 | 0 | 0 | 9 |
Chain B, HADH2 protein | 9 | 0 | 0 | 9 |
caspase-1 isoform alpha precursor | 1 | 0 | 0 | 1 |
Caspase-7 | 1 | 0 | 0 | 1 |
Inositol monophosphatase 1 | 2 | 0 | 0 | 2 |
Chain A, Vitamin D Nuclear Receptor | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 5 | 0 | 0 | 5 |
Vitamin D3 receptor | 0 | 0 | 1 | 1 |
PPM1D protein | 4 | 0 | 0 | 4 |
mitogen-activated protein kinase 1 | 6 | 0 | 0 | 6 |
nuclear receptor ROR-gamma isoform 1 | 9 | 0 | 0 | 9 |
Interferon beta | 16 | 0 | 0 | 16 |
Vitamin D-binding protein | 0 | 0 | 1 | 1 |
Vitamin D3 receptor | 0 | 2 | 3 | 9 |
Vitamin D3 receptor | 0 | 1 | 1 | 3 |
Retinoic acid receptor RXR-alpha | 0 | 0 | 1 | 1 |
Vitamin D3 receptor | 0 | 0 | 2 | 2 |
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial | 0 | 0 | 1 | 1 |
Vitamin D3 receptor | 0 | 1 | 1 | 2 |
Transporter | 0 | 1 | 0 | 1 |
Vitamin D3 receptor A | 0 | 0 | 2 | 2 |
Sodium/glucose cotransporter 1 | 0 | 2 | 3 | 5 |
Sodium/glucose cotransporter 2 | 0 | 3 | 3 | 6 |
Luciferase | 11 | 0 | 0 | 11 |
progesterone receptor | 13 | 0 | 0 | 13 |
nonstructural protein 1 | 2 | 0 | 0 | 2 |
67.9K protein | 8 | 0 | 0 | 8 |
activating transcription factor 6 | 11 | 0 | 0 | 11 |
histone deacetylase 9 isoform 3 | 2 | 0 | 0 | 2 |
Complement C5 | 0 | 0 | 1 | 1 |
Prostaglandin G/H synthase 1 | 0 | 3 | 0 | 3 |
Prostaglandin G/H synthase 1 | 0 | 3 | 0 | 3 |
ATAD5 protein, partial | 5 | 0 | 0 | 5 |
lysosomal alpha-glucosidase preproprotein | 3 | 0 | 0 | 3 |
serine/threonine-protein kinase mTOR isoform 1 | 2 | 0 | 0 | 2 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 3 | 0 | 0 | 3 |
short transient receptor potential channel 6 isoform 1 | 0 | 0 | 1 | 1 |
Toll-like receptor 4 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 3 | 0 | 5 |
Solute carrier family 22 member 1 | 0 | 5 | 0 | 9 |
5-hydroxytryptamine receptor 4 | 0 | 4 | 1 | 5 |
Potassium channel subfamily K member 2 | 0 | 1 | 0 | 1 |
Amyloid-beta precursor protein | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 4 | 0 | 4 |
Alpha-2A adrenergic receptor | 0 | 4 | 0 | 4 |
Neuronal acetylcholine receptor subunit alpha-4 | 1 | 0 | 0 | 1 |
Neuronal acetylcholine receptor subunit beta-2 | 1 | 0 | 0 | 1 |
D(2) dopamine receptor | 0 | 3 | 0 | 3 |
Alpha-2C adrenergic receptor | 0 | 2 | 0 | 2 |
D(1A) dopamine receptor | 0 | 3 | 0 | 3 |
UDP-glucuronosyltransferase 1A1 | 0 | 1 | 0 | 1 |
Sodium-dependent noradrenaline transporter | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 2A | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 2C | 0 | 4 | 0 | 4 |
D(3) dopamine receptor | 0 | 7 | 0 | 7 |
5-hydroxytryptamine receptor 2B | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 6 | 0 | 2 | 0 | 2 |
Potassium channel subfamily K member 10 | 0 | 1 | 0 | 1 |
Sodium-dependent dopamine transporter | 0 | 4 | 0 | 4 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 5 | 0 | 5 |
Cytochrome P450 1B1 | 0 | 3 | 0 | 3 |
Nuclear receptor subfamily 3 group C member 3 | 0 | 2 | 0 | 2 |
Multidrug and toxin extrusion protein 1 | 0 | 7 | 0 | 7 |
Smad3 | 6 | 0 | 0 | 6 |
cystic fibrosis transmembrane conductance regulator ATP-binding cassette sub-family C member 7 | 0 | 0 | 0 | 1 |
cytochrome P450 2D6 | 12 | 0 | 0 | 12 |
interleukin 8 | 4 | 0 | 0 | 4 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 4 | 0 | 0 | 4 |
cytochrome P450 3A4 isoform 1 | 8 | 0 | 0 | 8 |
60 kDa chaperonin | 0 | 2 | 0 | 2 |
60 kDa heat shock protein, mitochondrial | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-1 | 0 | 0 | 2 | 2 |
Nuclear receptor ROR-gamma | 5 | 1 | 1 | 7 |
10 kDa heat shock protein, mitochondrial | 0 | 2 | 0 | 2 |
Thiosulfate sulfurtransferase | 0 | 2 | 0 | 2 |
60 kDa chaperonin | 0 | 2 | 0 | 2 |
10 kDa chaperonin | 0 | 2 | 0 | 2 |
hypoxia-inducible factor 1 alpha subunit | 3 | 0 | 0 | 3 |
G | 12 | 0 | 0 | 12 |
Parkin | 1 | 0 | 0 | 1 |
aryl hydrocarbon receptor | 11 | 0 | 0 | 11 |
thyroid stimulating hormone receptor | 9 | 0 | 0 | 9 |
nuclear receptor subfamily 1, group I, member 2 | 2 | 0 | 0 | 2 |
huntingtin isoform 2 | 3 | 0 | 0 | 3 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
Voltage-dependent T-type calcium channel subunit alpha-1H | 0 | 1 | 0 | 1 |
HLA class I histocompatibility antigen, B alpha chain | 12 | 0 | 0 | 12 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
Voltage-dependent N-type calcium channel subunit alpha-1B | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 4 | 0 | 4 |
Inositol hexakisphosphate kinase 1 | 12 | 0 | 0 | 12 |
cytochrome P450 2C9, partial | 12 | 0 | 0 | 12 |
peripheral myelin protein 22 isoform 1 | 3 | 0 | 0 | 3 |
potassium voltage-gated channel subfamily H member 2 isoform d | 3 | 0 | 0 | 3 |
M-phase phosphoprotein 8 | 3 | 0 | 0 | 3 |
Muscarinic acetylcholine receptor M1 | 0 | 1 | 1 | 2 |
Muscarinic acetylcholine receptor M3 | 0 | 0 | 1 | 1 |
Muscarinic acetylcholine receptor M4 | 0 | 0 | 1 | 1 |
Muscarinic acetylcholine receptor M5 | 0 | 0 | 1 | 1 |
Muscarinic acetylcholine receptor M2 | 0 | 0 | 1 | 1 |
Peroxisome proliferator-activated receptor alpha | 0 | 0 | 2 | 2 |
Peroxisome proliferator-activated receptor gamma | 0 | 1 | 2 | 3 |
Peroxisome proliferator-activated receptor gamma | 0 | 0 | 2 | 2 |
Peroxisome proliferator-activated receptor alpha | 0 | 1 | 2 | 3 |
Phosphodiesterase | 0 | 3 | 0 | 3 |
Multidrug resistance-associated protein 5 | 0 | 0 | 0 | 1 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0 | 6 | 0 | 6 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 6 | 0 | 6 |
Plasminogen | 0 | 1 | 0 | 1 |
Coagulation factor XII | 0 | 2 | 0 | 2 |
Tissue-type plasminogen activator | 0 | 2 | 0 | 2 |
Vitamin K-dependent protein C | 0 | 1 | 0 | 1 |
Serine protease hepsin | 0 | 1 | 0 | 1 |
Ribosyldihydronicotinamide dehydrogenase [quinone] | 0 | 4 | 0 | 4 |
Multidrug and toxin extrusion protein 2 | 0 | 1 | 0 | 1 |
Cholinesterase | 0 | 5 | 1 | 6 |
Sodium/glucose cotransporter 2 | 0 | 0 | 1 | 1 |
Sodium/myo-inositol cotransporter 2 | 0 | 1 | 0 | 1 |
Solute carrier family 5 member 4 | 0 | 1 | 0 | 1 |
apical membrane antigen 1, AMA1 | 2 | 0 | 0 | 2 |
urokinase-type plasminogen activator precursor | 2 | 0 | 0 | 2 |
plasminogen precursor | 2 | 0 | 0 | 2 |
urokinase plasminogen activator surface receptor precursor | 2 | 0 | 0 | 2 |
Lysine-specific demethylase 4A | 0 | 1 | 0 | 1 |
Hypoxia-inducible factor 1-alpha | 0 | 0 | 1 | 1 |
Methylcytosine dioxygenase TET2 | 0 | 1 | 0 | 1 |
Deoxyhypusine hydroxylase | 0 | 1 | 0 | 1 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 10 | 0 | 0 | 10 |
PAX8 | 0 | 0 | 0 | 1 |
STAT3, partial | 0 | 1 | 0 | 1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 4 | 0 | 0 | 4 |
NPC intracellular cholesterol transporter 1 precursor | 1 | 0 | 0 | 1 |
cellular tumor antigen p53 isoform a | 2 | 0 | 0 | 2 |
tumor necrosis factor | 1 | 0 | 0 | 1 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 5 | 0 | 0 | 5 |
ras-related protein Rab-9A | 2 | 0 | 0 | 2 |
signal transducer and activator of transcription 1-alpha/beta isoform alpha | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A4 | 0 | 2 | 0 | 3 |
Sodium/potassium-transporting ATPase subunit alpha-1 | 0 | 2 | 0 | 2 |
Sodium/potassium-transporting ATPase subunit beta-1 | 0 | 2 | 0 | 2 |
Integrin beta-3 | 2 | 0 | 0 | 2 |
Sodium/potassium-transporting ATPase subunit alpha-2 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-3 | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
Sodium/potassium-transporting ATPase subunit beta-1 | 0 | 1 | 0 | 1 |
Integrin alpha-IIb | 2 | 0 | 0 | 2 |
Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-3 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit beta-2 | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 2 | 1 | 4 |
Sodium/potassium-transporting ATPase subunit alpha-2 | 0 | 2 | 0 | 2 |
Sodium/potassium-transporting ATPase subunit alpha-1 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit beta-3 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit gamma | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-4 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-4 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 4C1 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 4C1 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1A4 | 0 | 0 | 0 | 1 |
Kelch-like ECH-associated protein 1 | 0 | 0 | 1 | 1 |
Nuclear factor erythroid 2-related factor 2 | 0 | 0 | 1 | 2 |
glp-1 receptor, partial | 6 | 0 | 0 | 6 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 2 | 0 | 0 | 2 |
Histone H2A.x | 8 | 0 | 0 | 8 |
mu-type opioid receptor isoform MOR-1 | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 0 | 1 | 1 |
Epidermal growth factor receptor | 0 | 3 | 0 | 3 |
Tyrosine-protein kinase Lck | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase Fyn | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 3 | 0 | 3 |
POU domain, class 2, transcription factor 1 | 0 | 0 | 0 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
endonuclease IV | 3 | 0 | 0 | 3 |
Succinyl-diaminopimelate desuccinylase | 0 | 1 | 0 | 1 |
Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme 2 | 0 | 1 | 0 | 1 |
Endothelin-1 receptor | 0 | 1 | 0 | 1 |
Opioid receptor, delta 1b | 0 | 1 | 0 | 1 |
Opioid receptor homologue | 0 | 1 | 0 | 1 |
Proenkephalin-B | 0 | 0 | 1 | 1 |
Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 2 | 1 | 4 |
Delta-type opioid receptor | 0 | 1 | 1 | 3 |
Kappa-type opioid receptor | 0 | 1 | 1 | 3 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
Estrogen receptor | 0 | 4 | 2 | 6 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
Estrogen receptor beta | 0 | 3 | 2 | 5 |
Albumin | 0 | 3 | 2 | 6 |
Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase | 0 | 1 | 0 | 1 |
Flavin reductase (NADPH) | 0 | 0 | 1 | 1 |
Nuclear receptor ROR-gamma | 0 | 1 | 0 | 1 |
Xanthine dehydrogenase/oxidase | 0 | 2 | 0 | 2 |
Histamine H3 receptor | 0 | 2 | 0 | 2 |
thyrotropin-releasing hormone receptor | 2 | 0 | 0 | 2 |
Bile salt export pump | 0 | 4 | 0 | 4 |
Glucose-6-phosphate 1-dehydrogenase | 0 | 2 | 0 | 2 |
Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2J2 | 0 | 7 | 0 | 7 |
6-phosphogluconate dehydrogenase, decarboxylating | 0 | 1 | 0 | 1 |
Holo-[acyl-carrier-protein] synthase | 0 | 1 | 0 | 1 |
Sodium/bile acid cotransporter | 0 | 1 | 0 | 1 |
G-protein coupled receptor 35 | 0 | 1 | 1 | 2 |
CDGSH iron-sulfur domain-containing protein 1 | 0 | 2 | 0 | 2 |
Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 | 0 | 1 | 0 | 1 |
Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0 | 1 | 0 | 1 |
hypothetical protein, conserved | 1 | 0 | 0 | 1 |
fructose-bisphosphate aldolase A | 1 | 0 | 0 | 1 |
glyceraldehyde-3-phosphate dehydrogenase isoform 1 | 1 | 0 | 0 | 1 |
Pancreatic triacylglycerol lipase | 0 | 2 | 0 | 2 |
Urokinase-type plasminogen activator | 0 | 1 | 0 | 1 |
Plasminogen activator inhibitor 1 | 0 | 1 | 0 | 1 |
Urokinase-type plasminogen activator | 0 | 1 | 0 | 1 |
72 kDa type IV collagenase | 0 | 1 | 0 | 1 |
Matrilysin | 0 | 1 | 0 | 1 |
L-selectin | 0 | 1 | 0 | 1 |
P-selectin | 0 | 1 | 0 | 1 |
E-selectin | 0 | 1 | 0 | 1 |
Prolyl 4-hydroxylase subunit alpha-1 | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-5 | 0 | 2 | 0 | 2 |
Alpha-synuclein | 0 | 2 | 0 | 2 |
4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6 | 0 | 1 | 0 | 1 |
Squalene monooxygenase | 0 | 1 | 0 | 1 |
Autoinducer 2-binding periplasmic protein LuxP | 0 | 1 | 0 | 1 |
Anthrax toxin receptor 2 | 0 | 1 | 0 | 1 |
Disintegrin and metalloproteinase domain-containing protein 17 | 1 | 1 | 0 | 2 |
Lactoperoxidase | 0 | 0 | 0 | 1 |
Polypeptide N-acetylgalactosaminyltransferase 2 | 0 | 1 | 1 | 2 |
Alpha-(1,3)-fucosyltransferase 7 | 0 | 1 | 0 | 1 |
CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 | 0 | 1 | 0 | 1 |
Reverse transcriptase/RNaseH | 0 | 1 | 0 | 1 |
Toll-like receptor 2 | 0 | 1 | 0 | 1 |
Thymidine kinase | 0 | 1 | 0 | 1 |
ClpP | 2 | 0 | 0 | 2 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 4 | 0 | 0 | 4 |
POU domain, class 2, transcription factor 2 | 0 | 0 | 0 | 1 |
Transitional endoplasmic reticulum ATPase | 0 | 1 | 0 | 1 |
Purine nucleoside phosphorylase | 0 | 0 | 1 | 1 |
Solute carrier family 22 member 6 | 0 | 3 | 0 | 6 |
Glucagon-like peptide 1 receptor | 0 | 0 | 1 | 1 |
Glucagon-like peptide 1 receptor | 0 | 1 | 1 | 2 |
Glucagon receptor | 0 | 0 | 1 | 1 |
Glucagon receptor | 0 | 0 | 1 | 1 |
Asialoglycoprotein receptor 1 | 0 | 1 | 1 | 2 |
Lysine-specific histone demethylase 1A | 0 | 1 | 0 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, Protein (female-specific Histamine Binding Protein 2) | 0 | 0 | 1 | 1 |
aryl hydrocarbon receptor nuclear translocator | 0 | 0 | 0 | 1 |
transforming acidic coiled-coil-containing protein 3 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 3 | 0 | 3 | 0 | 4 |
Plasma kallikrein | 0 | 0 | 0 | 3 |
Macrophage migration inhibitory factor | 0 | 2 | 0 | 2 |
Histamine H2 receptor | 0 | 3 | 2 | 5 |
5-hydroxytryptamine receptor 1D | 0 | 0 | 0 | 1 |
Histamine H1 receptor | 0 | 1 | 2 | 3 |
Histamine H1 receptor | 0 | 2 | 1 | 3 |
Metabotropic glutamate receptor 5 | 0 | 1 | 1 | 2 |
Histamine H1 receptor | 0 | 2 | 2 | 4 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 0 | 1 | 4 |
Histamine H2 receptor | 2 | 0 | 2 | 4 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 0 | 1 | 4 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 0 | 1 | 4 |
Histamine N-methyltransferase | 0 | 1 | 0 | 1 |
Glutaminyl-peptide cyclotransferase | 0 | 1 | 0 | 1 |
Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 3 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 0 | 1 | 4 |
Solute carrier family 22 member 1 | 0 | 3 | 0 | 5 |
Equilibrative nucleoside transporter 4 | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 0 | 1 | 4 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Histamine H4 receptor | 0 | 1 | 0 | 1 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Carboxylic ester hydrolase | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 3 | 0 | 5 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 0 | 1 | 4 |
Histamine H3 receptor | 0 | 2 | 2 | 4 |
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 | 0 | 2 | 0 | 3 |
transcriptional regulator ERG isoform 3 | 1 | 0 | 0 | 1 |
Acid-sensing ion channel 3 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 3 | 0 | 3 |
Albumin | 0 | 0 | 1 | 1 |
Fatty acid-binding protein, intestinal | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 2 |
UDP-glucuronosyltransferase 2B7 | 0 | 0 | 0 | 2 |
Acetylcholinesterase | 0 | 4 | 0 | 4 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Caspase-1 | 0 | 1 | 0 | 1 |
Substance-P receptor | 0 | 3 | 0 | 3 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 2 |
UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 1 |
Aldo-keto reductase family 1 member C3 | 0 | 1 | 0 | 1 |
Caspase-3 | 0 | 1 | 0 | 1 |
Caspase-4 | 0 | 1 | 0 | 1 |
4-aminobutyrate aminotransferase, mitochondrial | 0 | 1 | 0 | 1 |
Caspase-5 | 0 | 1 | 0 | 1 |
Caspase-9 | 0 | 1 | 0 | 1 |
Acid-sensing ion channel 1 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 2 |
Solute carrier family 22 member 20 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 8 | 0 | 3 | 0 | 4 |
Solute carrier family 22 member 6 | 0 | 2 | 0 | 3 |
Dehydrogenase/reductase SDR family member 9 | 0 | 1 | 0 | 1 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 2 | 0 | 0 | 2 |
NPYLR7B | 0 | 0 | 1 | 1 |
beta-2 adrenergic receptor | 2 | 0 | 0 | 2 |
hexokinase-4 isoform 1 | 1 | 0 | 0 | 1 |
glucokinase regulatory protein | 1 | 0 | 0 | 1 |
Beta-2 adrenergic receptor | 0 | 2 | 1 | 3 |
Alpha-1B adrenergic receptor | 0 | 2 | 0 | 2 |
Beta-1 adrenergic receptor | 0 | 3 | 2 | 6 |
Beta-2 adrenergic receptor | 0 | 0 | 1 | 1 |
Alpha-2B adrenergic receptor | 0 | 2 | 0 | 2 |
D(4) dopamine receptor | 0 | 1 | 0 | 1 |
Alpha-2C adrenergic receptor | 0 | 2 | 0 | 2 |
Alpha-2A adrenergic receptor | 0 | 2 | 0 | 2 |
Alpha-1D adrenergic receptor | 0 | 2 | 0 | 2 |
Beta-adrenergic receptor kinase 1 | 0 | 0 | 1 | 1 |
Beta-3 adrenergic receptor | 0 | 0 | 1 | 1 |
Beta-3 adrenergic receptor | 0 | 1 | 1 | 2 |
Beta-1 adrenergic receptor | 0 | 2 | 1 | 3 |
Alpha-1A adrenergic receptor | 0 | 3 | 0 | 3 |
Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
Taste receptor type 2 member 38 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 39 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 40 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 41 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 43 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 31 | 0 | 0 | 2 | 2 |
Taste receptor type 2 member 45 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 46 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 30 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 19 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 20 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 50 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 60 | 0 | 0 | 2 | 2 |
Beta-2 adrenergic receptor | 0 | 1 | 1 | 2 |
Taste receptor type 2 member 42 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 16 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 14 | 0 | 0 | 2 | 3 |
Taste receptor type 2 member 13 | 0 | 0 | 2 | 2 |
Taste receptor type 2 member 10 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 9 | 0 | 0 | 2 | 2 |
Taste receptor type 2 member 8 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 7 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 5 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 4 | 0 | 0 | 2 | 2 |
Taste receptor type 2 member 3 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 1 | 0 | 0 | 1 | 1 |
2,3-bisphosphoglycerate-independent phosphoglycerate mutase | 1 | 0 | 0 | 1 |
Neprilysin | 0 | 1 | 0 | 1 |
Thromboxane A2 receptor | 0 | 1 | 0 | 4 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 3 | 0 | 3 |
Type-1 angiotensin II receptor | 0 | 2 | 1 | 3 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 3 | 0 | 3 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 3 | 0 | 3 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 3 | 0 | 3 |
Platelet glycoprotein VI | 0 | 1 | 3 | 5 |
Type-1 angiotensin II receptor | 0 | 2 | 1 | 3 |
5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
cytochrome P450 2D6 isoform 1 | 1 | 0 | 0 | 1 |
Cytochrome P450 1A1 | 0 | 2 | 0 | 2 |
Cytochrome P450 1A2 | 0 | 1 | 0 | 1 |
Myeloperoxidase | 0 | 2 | 0 | 2 |
Cytochrome P450 2C11 | 0 | 1 | 0 | 1 |
Aromatase | 0 | 2 | 0 | 2 |
Metabotropic glutamate receptor 1 | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Nociceptin receptor | 0 | 1 | 0 | 1 |
Melatonin receptor type 1A | 0 | 2 | 1 | 3 |
Melatonin receptor type 1C | 0 | 0 | 1 | 1 |
Melatonin receptor type 1A | 0 | 1 | 1 | 2 |
Melatonin receptor type 1B | 0 | 2 | 1 | 3 |
Melatonin receptor type 1C | 0 | 1 | 1 | 2 |
Melatonin receptor type 1B | 0 | 1 | 1 | 2 |
Palmitoleoyl-protein carboxylesterase NOTUM | 0 | 1 | 0 | 1 |
Carboxylic ester hydrolase | 0 | 2 | 0 | 2 |
Thioredoxin reductase | 0 | 1 | 0 | 1 |
Flavodoxin | 0 | 0 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 2 | 0 | 2 |
Lanosterol 14-alpha demethylase | 0 | 1 | 0 | 1 |
Vpr | 2 | 0 | 0 | 2 |
cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 2 | 0 | 2 |
Aurora kinase A | 0 | 1 | 0 | 1 |
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A | 0 | 2 | 0 | 2 |
cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 3 | 1 | 4 |
3',5'-cyclic-AMP phosphodiesterase | 0 | 1 | 0 | 1 |
Dual specificity protein kinase TTK | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 2 | 0 | 2 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 2 | 0 | 2 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 2 | 0 | 2 |
cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 2 | 0 | 2 |
Aurora kinase B | 0 | 1 | 0 | 1 |
Inner centromere protein | 0 | 1 | 0 | 1 |
Phosphodiesterase | 0 | 1 | 0 | 1 |
Nuclear receptor corepressor 1 | 0 | 1 | 0 | 1 |
Integrin beta-1 | 0 | 1 | 0 | 1 |
Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Integrin alpha-4 | 0 | 1 | 0 | 1 |
Nuclear receptor corepressor 2 | 0 | 1 | 0 | 1 |
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 | 0 | 0 | 0 | 1 |
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 | 0 | 0 | 0 | 1 |
Chain A, Hth-type Transcriptional Regulator Ttgr | 0 | 0 | 1 | 1 |
Chain A, Hth-type Transcriptional Regulator Ttgr | 0 | 0 | 1 | 1 |
Chain A, Transthyretin | 0 | 0 | 1 | 1 |
Chain A, Transthyretin | 0 | 0 | 1 | 1 |
Chain A, Transthyretin | 0 | 0 | 1 | 1 |
Chain A, Transthyretin | 0 | 0 | 1 | 1 |
Chain B, Transthyretin | 0 | 0 | 1 | 1 |
Chain A, Transthyretin | 0 | 0 | 1 | 1 |
Chain B, Transthyretin | 0 | 0 | 1 | 1 |
Chain A, Mitogen-activated protein kinase 14 | 0 | 1 | 0 | 1 |
Chain A, Mitogen-activated protein kinase 14 | 0 | 1 | 0 | 1 |
Chain A, Mitogen-activated protein kinase 14 | 0 | 1 | 0 | 1 |
Chain A, Mitogen-activated protein kinase 14 | 0 | 1 | 0 | 1 |
Chain A, Mitogen-activated protein kinase 14 | 0 | 1 | 0 | 1 |
Chain A, Mitogen-activated protein kinase 14 | 0 | 1 | 0 | 1 |
Chain A, Mitogen-activated protein kinase 14 | 0 | 1 | 0 | 1 |
Chain A, Mitogen-activated protein kinase 14 | 0 | 1 | 0 | 1 |
Chain A, Mitogen-activated protein kinase 14 | 0 | 1 | 0 | 1 |
Neuraminidase | 0 | 1 | 0 | 1 |
cytochrome P450 2C9 precursor | 2 | 0 | 0 | 2 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Rap guanine nucleotide exchange factor 3 | 5 | 0 | 0 | 5 |
Calmodulin-1 | 0 | 1 | 0 | 1 |
17-beta-hydroxysteroid dehydrogenase type 1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
Carbonyl reductase [NADPH] 1 | 0 | 2 | 0 | 2 |
Tyrosine-protein phosphatase non-receptor type 1 | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] A | 0 | 4 | 0 | 4 |
Amine oxidase [flavin-containing] B | 0 | 4 | 2 | 6 |
Multidrug resistance-associated protein 1 | 0 | 3 | 1 | 6 |
Receptor-type tyrosine-protein kinase FLT3 | 0 | 1 | 0 | 1 |
17-beta-hydroxysteroid dehydrogenase type 2 | 0 | 1 | 0 | 1 |
Lactoylglutathione lyase | 0 | 1 | 0 | 1 |
Substance-K receptor | 0 | 1 | 0 | 1 |
Integrase | 0 | 1 | 0 | 1 |
Inositol polyphosphate multikinase | 0 | 1 | 0 | 1 |
Prenyltransferase homolog | 0 | 0 | 0 | 1 |
Inositol hexakisphosphate kinase 2 | 0 | 1 | 0 | 1 |
Sodium/iodide cotransporter | 0 | 1 | 0 | 1 |
Peptidylglycine alpha-amidating monooxygenase | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 1 | 0 | 2 |
Chain A, Protein (fibroblast Growth Factor (fgf) Receptor 1) | 0 | 1 | 0 | 1 |
serine-protein kinase ATM isoform a | 1 | 0 | 0 | 1 |
tyrosine-protein kinase Yes | 1 | 0 | 0 | 1 |
Proto-oncogene tyrosine-protein kinase Src | 0 | 1 | 0 | 1 |
Platelet-derived growth factor receptor beta | 0 | 1 | 0 | 1 |
Insulin receptor | 0 | 1 | 0 | 1 |
Fibroblast growth factor receptor 1 | 0 | 1 | 1 | 2 |
Proto-oncogene tyrosine-protein kinase Src | 0 | 1 | 0 | 1 |
Vascular endothelial growth factor receptor 1 | 0 | 1 | 0 | 1 |
Platelet-derived growth factor receptor alpha | 0 | 1 | 0 | 1 |
Fibroblast growth factor receptor 2 | 0 | 1 | 0 | 1 |
Fibroblast growth factor receptor 4 | 0 | 1 | 0 | 1 |
Fibroblast growth factor receptor 3 | 0 | 1 | 1 | 2 |
Vascular endothelial growth factor receptor 3 | 0 | 1 | 0 | 1 |
Vascular endothelial growth factor receptor 2 | 0 | 1 | 1 | 2 |
Tyrosine-protein kinase CSK | 0 | 1 | 0 | 1 |
Dual specificity mitogen-activated protein kinase kinase 1 | 0 | 1 | 0 | 1 |
Platelet-derived growth factor receptor beta | 0 | 1 | 0 | 1 |
Serine-protein kinase ATM | 0 | 1 | 0 | 1 |
Sodium/potassium/calcium exchanger 4 | 0 | 1 | 1 | 2 |
Sodium/potassium/calcium exchanger 2 | 0 | 1 | 1 | 2 |
Glycine receptor subunit alpha-1 | 0 | 4 | 0 | 4 |
Glycine receptor subunit beta | 0 | 4 | 0 | 4 |
Glycine receptor subunit alpha-2 | 0 | 4 | 0 | 4 |
Glycine receptor subunit alpha-3 | 0 | 4 | 0 | 4 |
Nuclear factor NF-kappa-B p105 subunit | 0 | 1 | 0 | 1 |
Nuclear factor NF-kappa-B p100 subunit | 0 | 1 | 0 | 1 |
Transcription factor p65 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
Adenosine receptor A3 | 0 | 1 | 0 | 1 |
Adenosine receptor A2a | 0 | 1 | 0 | 1 |
Adenosine receptor A2b | 0 | 0 | 1 | 1 |
Adenosine receptor A1 | 0 | 1 | 0 | 1 |
Chain A, Activated Factor Xa Heavy Chain | 0 | 1 | 0 | 1 |
Suppressor of tumorigenicity 14 protein | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] B | 0 | 2 | 0 | 2 |
Amine oxidase [flavin-containing] A | 0 | 2 | 1 | 3 |
Sodium channel protein type 9 subunit alpha | 0 | 1 | 0 | 1 |
Renin | 0 | 1 | 0 | 1 |
Chain A, Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
Chain A, Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
Chain B, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | 0 | 1 | 0 | 1 |
cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 1 | 2 |
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | 0 | 1 | 0 | 1 |
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B | 0 | 1 | 0 | 1 |
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 0 | 1 | 0 | 1 |
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha | 0 | 1 | 0 | 1 |
Cystic fibrosis transmembrane conductance regulator | 0 | 0 | 2 | 2 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily E member 1 | 0 | 1 | 0 | 1 |
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha | 0 | 1 | 0 | 1 |
Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha' | 0 | 1 | 0 | 1 |
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 0 | 1 | 0 | 1 |
Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 0 | 1 | 0 | 1 |
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta | 0 | 1 | 0 | 1 |
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha' | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily KQT member 1 | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
Synaptic vesicular amine transporter | 0 | 1 | 0 | 1 |
High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A | 0 | 1 | 0 | 1 |
Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 0 | 1 | 0 | 1 |
Sodium channel protein type 5 subunit alpha | 0 | 2 | 0 | 2 |
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | 0 | 1 | 0 | 1 |
Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 7B | 0 | 1 | 0 | 1 |
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 0 | 1 | 0 | 1 |
Nuclear receptor subfamily 2 group E member 1 | 0 | 0 | 1 | 1 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 1 | 0 | 0 | 1 |
eyes absent homolog 2 isoform a | 2 | 0 | 0 | 2 |
neuropeptide S receptor isoform A | 1 | 0 | 0 | 1 |
Peroxisome proliferator-activated receptor delta | 0 | 0 | 1 | 1 |
Peroxisome proliferator-activated receptor delta | 0 | 1 | 1 | 2 |
Solute carrier family 22 member 1 | 0 | 2 | 0 | 3 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 2 |
Solute carrier family 22 member 5 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 3 | 0 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 2 |
Potassium voltage-gated channel subfamily A member 1 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 4 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 4 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 3 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 5 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 4 | 0 | 0 | 0 | 1 |
Ubiquitin-like modifier activating enzyme 2 | 0 | 1 | 0 | 1 |
SUMO1 activating enzyme subunit 1 | 0 | 1 | 0 | 1 |
hexokinase | 0 | 1 | 0 | 1 |
DNA polymerase beta | 1 | 0 | 0 | 1 |
SUMO-conjugating enzyme UBC9 | 0 | 1 | 0 | 1 |
eukaryotic translation initiation factor 4 gamma 1 isoform 4 | 0 | 1 | 0 | 1 |
eukaryotic translation initiation factor 4E isoform 1 | 0 | 1 | 0 | 1 |
Vif | 0 | 1 | 0 | 1 |
Tat | 0 | 1 | 0 | 1 |
DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 0 | 1 | 0 | 1 |
bifunctional UDP-N-acetylglucosamine pyrophosphorylase/glucosamine-1-phosphate N-acetyltransferase | 0 | 1 | 0 | 1 |
Glutamate receptor 1 | 1 | 0 | 0 | 1 |
Glutamate receptor 3 | 1 | 0 | 0 | 1 |
Glutamate receptor 4 | 1 | 0 | 0 | 1 |
Chain A, Trp Rna-binding Attenuation Protein | 0 | 0 | 1 | 1 |
Chain K, Trp Rna-binding Attenuation Protein | 0 | 0 | 1 | 1 |
Chain B, tryptophanyl-tRNA synthetase | 0 | 0 | 1 | 1 |
Chain C, Tryptophanyl-tRNA synthetase II | 0 | 0 | 1 | 1 |
Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 1 | 0 | 1 |
Stromelysin-1 | 0 | 1 | 0 | 1 |
Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 2 |
Tryptophan 2,3-dioxygenase | 0 | 1 | 0 | 2 |
Large neutral amino acids transporter small subunit 1 | 0 | 3 | 0 | 3 |
SLC16A10 protein | 0 | 0 | 0 | 2 |
Uracil nucleotide/cysteinyl leukotriene receptor | 0 | 1 | 0 | 1 |
Tryprostatin B synthase | 0 | 0 | 0 | 1 |
2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase | 0 | 0 | 1 | 1 |
Monocarboxylate transporter 10 | 0 | 0 | 0 | 2 |
Phospholipase A-2-activating protein | 0 | 1 | 0 | 1 |
Chain A, CHORISMATE MUTASE | 0 | 1 | 0 | 1 |
Chain A, TYROSYL-tRNA SYNTHETASE | 0 | 0 | 1 | 1 |
Urease subunit alpha | 0 | 1 | 0 | 1 |
Urease subunit beta | 0 | 1 | 0 | 1 |
Olfactory receptor 51E2 | 0 | 0 | 1 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Solute carrier family 2, facilitated glucose transporter member 9 | 0 | 1 | 1 | 2 |
Guanine deaminase | 0 | 1 | 0 | 1 |
Chain A, Arginase 1 | 0 | 1 | 0 | 1 |
Leukotriene B4 receptor 2 | 0 | 0 | 1 | 1 |
Glycoprotein | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M2 | 0 | 0 | 1 | 1 |
Catechol O-methyltransferase | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily A member 3 | 0 | 1 | 0 | 1 |
Chloroquine resistance transporter | 0 | 1 | 0 | 1 |
DNA polymerase eta isoform 1 | 1 | 0 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |